Increased B cell activation is present in JAK2V617F-mutated, CALR-mutated and triple-negative essential thrombocythemia

Essential thrombocythemia (ET) is a BCL-ABL1-negative myeloproliferative neoplasm. We have reported that increased activated B cells can facilitate platelet production mediated by cytokines regardless JAK2 mutational status in ET. Recently, calreticulin (CALR) mutations were discovered in ~30% JAK2/...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Ken-Hong, Chen, Caleb Gon-Shen, Chang, Yu-Cheng, Chiang, Yi-Hao, Kao, Chen-Wei, Wang, Wei-Ting, Chang, Chiao-Yi, Huang, Ling, Lin, Ching-Sung, Cheng, Chun-Chia, Cheng, Hung-I, Su, Nai-Wen, Lin, Johnson, Chang, Yi-Fang, Chang, Ming-Chih, Hsieh, Ruey-Kuen, Lin, Huan-Chau, Kuo, Yuan-Yeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464803/
https://www.ncbi.nlm.nih.gov/pubmed/28415571
http://dx.doi.org/10.18632/oncotarget.16381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464803/
https://www.ncbi.nlm.nih.gov/pubmed/28415571
http://dx.doi.org/10.18632/oncotarget.16381

Ejemplares similares